15 completed, 4 unknown, 2 not yet recruiting, 1 withdrawn. 10 Phase 1, 8 Phase 3, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
| Phase 3 | 8 | Completed 3, Not yet recruiting 2, Unknown 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow levamlodipine: new trials by email Literature Review of levamlodipine trials Research Report on levamlodipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure. Amlodipine - Hypertension, Oedema | Phase 3 | Not yet recruiting | Zentiva, k.s. | 344 | 2026-11-30 | 2026-06-01 |
| A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients SYH9056, Levamlodipine, Valsartan - Mild-to-moderate Essential Hypertension | Phase 3 | Not yet recruiting | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 606 | 2025-01-24 | 2025-01-13 |
| Efficacy and Safety of Leningrado Association in the Treatment of Hypertension LENINGRADO association, Indapamide SR 1.5 MG, Levamlodipine 2.5/ 5 mg - Arterial Hypertension | Phase 3 | Withdrawn | EMS | 2022-04-01 | 2022-07-27 | |
| Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension AGSAVI, AGLS - Hypertension | Phase 3 | Unknown | Ahn-Gook Pharmaceuticals Co.,Ltd | 306 | 2021-02-01 | 2020-12-29 |
| Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension S-amlodipine 2.5mg, Amlodipine 5mg - Essential Hypertension | Unknown | Ahn-Gook Pharmaceuticals Co.,Ltd | 80 | 2020-10-28 | 2020-11-12 | |
| Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects Amlodipine 10 mg, Levamlodipine 5 mg - Healthy Subjects | Phase 1 | Completed | The Affiliated Hospital of Qingdao University | 48 | 2018-11-13 | 2020-06-05 |
| Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects Levamlodipine, Amlodipine, Amlodipine, Levamlodipine - Hypertension | Phase 1 | Completed | Conjupro Biotherapeutics, Inc. | 36 | 2018-05-31 | 2021-09-16 |
| S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension S-amlodipine 2.5mg + Chlorthalidone 25mg, S-amlodipine 2.5mg + Telmisartan 40mg - Essential Hypertension | Phase 4 | Unknown | Seoul National University Bundang Hospital | 170 | 2015-12-02 | 2017-07-21 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 48 | 2015-02-01 | 2015-07-08 |
| CKD-828 (80/5mg) Pharmacokinetic Study CKD-828, Telmisartan, S-amlodipine - Hypertension | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 69 | 2014-09-01 | 2015-04-10 |
| Efficacy and Safety of TELMINUVO to Stage 2 Hypertension TELMINUVO Tab. (80/2.5mg), TELMINUVO Tab. (80/5mg), S-amlodipine 2.5mg - Hypertension | Phase 3 | Unknown | Chong Kun Dang Pharmaceutical | 200 | 2014-01-01 | 2013-11-14 |
| Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg, atorvastatin 40mg - Essential Hypertension, Hyperlipidemia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2013-04-01 | 2013-08-01 |
| Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg, Telmisartan 80mg and S-amlodipine 5mg - Essential Hypertension, Hyperlipidemia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2013-04-01 | 2013-08-01 |
| Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet - Hypertension | Phase 4 | Completed | Neutec Ar-Ge San ve Tic A.Ş | 43 | 2013-03-20 | 2018-06-15 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60) Exforge tab. 10/160mg, Lodivixx tab. 5/160mg - Healthy Male Subjects | Phase 1 | Completed | Hanlim Pharm. Co., Ltd. | 53 | 2013-03-01 | 2018-08-03 |
| Efficacy and Safety of CKD-828 to Stage 2 Hypertension CKD-828 2.5/40mg, CKD-828 5/40mg, CKD-828 5/80mg - Hypertension | Phase 3 | Completed | Chong Kun Dang Pharmaceutical | 103 | 2012-07-01 | 2013-06-21 |
| Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects Exforge tab. 10/160mg, Lodivixx tab. 5/160mg - Healthy Male Subjects | Phase 1 | Completed | Hanlim Pharm. Co., Ltd. | 40 | 2012-07-01 | 2013-03-26 |
| CKD-828 S-Amlodipine Non-Responder Trial CKD-828 2.5/40mg, CKD-828 2.5/80mg, S-Amlodipine 2.5mg - Hypertension | Phase 3 | Completed | Chong Kun Dang Pharmaceutical | 187 | 2011-08-01 | 2012-11-14 |
| CKD-828 Drug Interaction Study (Telmisartan) Telmisartan 80mg, S-amlodipine 5mg, Telmisartan 80mg - Healthy Male Volunteers | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 32 | 2011-06-01 | 2011-09-07 |
| CKD-828 Drug Interaction Study (S-amlodipine) S-amlodipine 5mg,Telmisartan 80mg, S-amlodipine 5mg - Healthy Male Volunteers | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2011-05-01 | 2011-08-30 |
Showing 20 of 22. Sign in to see all of them.
Hypertension (13) · Essential Hypertension (6) · Edema (2) · Hyperlipidemias (2)
Chong Kun Dang Pharmaceutical (10) · Ahn-Gook Pharmaceuticals Co.,Ltd (2) · Hanlim Pharm. Co., Ltd. (2) · Affiliated Hospital of North Sichuan Medical College (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Conjupro Biotherapeutics, Inc. (1) · EMS (1) · Neutec Ar-Ge San ve Tic A.Ş (1) · Seoul National University Bundang Hospital (1) · The Affiliated Hospital of Qingdao University (1) · Zentiva, k.s. (1)
South Korea (14) · China (1) · Turkey (Türkiye) (1) · United States (1)
Kyun S Bae, Ph.D. (2) · Young-Ran Yoon (2) · Chang-kyu Park, Ph.D (1) · Chul-ho Kim, Ph.D (1) · Eun-joo Jo, Ph.D (1) · Eung Ju Kim, PhD (1) · Gyu-Rok Han, Ph.D (1) · Ho-Joong Yoon, Ph.D (1) · Jae Gook Shin, MD (1) · Jang-ho Bae, Ph.D (1) · Jong-jin Kim, Ph.D (1) · KyoungSook Kim, PhD (1) · Min Soo Park, Ph. D (1) · Min Soo Park, Ph.D (1) · Sae-Joong Lim, Ph.D (1)